Log In
Print
BCIQ
Print
Print this Print this
 

PTI-721

  Manage Alerts
Collapse Summary General Information
Company Pain Therapeutics Inc.
DescriptionAbuse-resistant opioid
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation

Partner

Pfizer Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today